Skip to main content
NutriBand Inc. logo

NutriBand Inc. — Investor Relations & Filings

Ticker · NTRB ISIN · US67092M2089 LEI · 549300OZV3WLQQWOD724 US Manufacturing
Filings indexed 254 across all filing types
Latest filing 2026-05-18 Annual Report
Country US United States of America
Listing US NTRB

About NutriBand Inc.

https://nutriband.com/

NutriBand Inc. is a biopharmaceutical company focused on the development of transdermal pharmaceutical products. The company's core activity involves creating advanced drug delivery platforms to enhance patient safety and outcomes. Its primary technology is AVERSA™, a patented abuse-deterrent system designed for transdermal patches. This technology aims to prevent the misuse and abuse of potent medications, particularly opioids, by releasing aversive agents if tampering occurs. NutriBand's lead product under development is an abuse-deterrent transdermal system for fentanyl. The company is engaged in research, development, and manufacturing scale-up of its innovative drug delivery solutions.

Recent filings

Filing Released Lang Actions
AMENDMENT NO. 1 TO FORM 10-K
Annual Report
2026-05-18 English
10-K - NutriBand Inc. (0001676047) (Filer)
Annual Report
2026-04-29 English
8-K - NutriBand Inc. (0001676047) (Filer)
Regulatory Filings
2026-04-07 English
8-K Filing
Regulatory Filings
2026-02-13 English
8-K Filing
Regulatory Filings
2026-02-03 English
CURRENT REPORT
Regulatory Filings
2025-12-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.